2,4-Difluorobenzylamine

We are 2,4-Difluorobenzylamine CAS:72235-52-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,4-Difluorobenzylamine
CAS.NO:72235-52-0
Synonyms:2,4-Difluorobenzylamine
(2,4-difluorophenyl)methanamine
Molecular Formula:C7H7F2N
Molecular Weight:143.13400
 
Physical and Chemical Properties:
Density:1.204
Melting point:ºC
Boiling point:82-84ºC
Flash point:155°F
Index of Refraction:1.49
 
Specification:
Appearance:Colourless to light yellow clear liquid
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2,4-Difluorobenzylamine


Related News: Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added.[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-carbamic acid ethyl ester CAS:318515-70-7 The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.212322-56-0 Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.[dimethylamino-(1-oxidopyridin-1-ium-2-yl)sulfanylmethylidene]-dimethylazanium,tetrafluoroborate At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.

Related Products
Product Name
4-phenyl-N-[4-(9-phenylcarbazol-3-yl)phenyl]aniline View Details
pentetic acid View Details
4-Aminobenzotrifluoride View Details
methyl 4-(chlorocarbonothioyloxy)benzoate manufacturer 1-(benzotriazol-1-yl)octan-1-one manufacturer 2,8-Dibromodibenzothiophene manufacturer 2-amino-5-methylphenol manufacturer 2-fluorobenzoic acid manufacturer